Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Psilocybin for Phantom Limb Pain
NCT05224336Phase 1Active, not recruiting
- Sponsor
- University of California, San Diego
- Start
- Oct 2022
- Primary completion
- Mar 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of psilocybin in phantom limb pain (PLP) (2 arms), sponsored by University of California, San Diego. Primary endpoint: Phantom Limb Pain Intensity at 2 weeks. Started Oct 2022; status: active, not recruiting.
02
Drugs
psilocybin
03
Conditions
phantom limb pain (PLP)
Beyond the preview
Go deeper on NCT05224336.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05224336.